Logo image of ZCMD

ZHONGCHAO INC-CLASS A (ZCMD) Stock Fundamental Analysis

USA - NASDAQ:ZCMD - KYG9897X1152 - Common Stock

0.747 USD
-0.07 (-8.9%)
Last: 10/10/2025, 9:04:20 PM
0.73 USD
-0.02 (-2.28%)
After Hours: 10/10/2025, 9:04:20 PM
Fundamental Rating

3

Overall ZCMD gets a fundamental rating of 3 out of 10. We evaluated ZCMD against 75 industry peers in the Diversified Consumer Services industry. ZCMD has a great financial health rating, but its profitability evaluates not so good. ZCMD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZCMD has reported negative net income.
In the past year ZCMD has reported a negative cash flow from operations.
In multiple years ZCMD reported negative net income over the last 5 years.
In multiple years ZCMD reported negative operating cash flow during the last 5 years.
ZCMD Yearly Net Income VS EBIT VS OCF VS FCFZCMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.46%, ZCMD is doing worse than 61.33% of the companies in the same industry.
ZCMD has a Return On Equity (-8.38%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.46%
ROE -8.38%
ROIC N/A
ROA(3y)-18.84%
ROA(5y)-8.61%
ROE(3y)-25.29%
ROE(5y)-12.23%
ROIC(3y)N/A
ROIC(5y)N/A
ZCMD Yearly ROA, ROE, ROICZCMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

ZCMD has a Gross Margin (52.49%) which is in line with its industry peers.
ZCMD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ZCMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y-3.95%
ZCMD Yearly Profit, Operating, Gross MarginsZCMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

8

2. Health

2.1 Basic Checks

ZCMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZCMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ZCMD has more shares outstanding
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ZCMD Yearly Shares OutstandingZCMD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZCMD Yearly Total Debt VS Total AssetsZCMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.79 indicates that ZCMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
ZCMD's Altman-Z score of 2.79 is fine compared to the rest of the industry. ZCMD outperforms 69.33% of its industry peers.
There is no outstanding debt for ZCMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.79
ROIC/WACCN/A
WACC7.54%
ZCMD Yearly LT Debt VS Equity VS FCFZCMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ZCMD has a Current Ratio of 8.15. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
ZCMD's Current ratio of 8.15 is amongst the best of the industry. ZCMD outperforms 96.00% of its industry peers.
ZCMD has a Quick Ratio of 8.15. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
ZCMD's Quick ratio of 8.15 is amongst the best of the industry. ZCMD outperforms 96.00% of its industry peers.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 8.15
ZCMD Yearly Current Assets VS Current LiabilitesZCMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

ZCMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.72%, which is quite impressive.
The Revenue for ZCMD has decreased by -24.64% in the past year. This is quite bad
The Revenue has been growing slightly by 1.29% on average over the past years.
EPS 1Y (TTM)94.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.44%
Revenue 1Y (TTM)-24.64%
Revenue growth 3Y-0.89%
Revenue growth 5Y1.29%
Sales Q2Q%-32.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZCMD Yearly Revenue VS EstimatesZCMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZCMD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZCMD Price Earnings VS Forward Price EarningsZCMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZCMD Per share dataZCMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZCMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZHONGCHAO INC-CLASS A

NASDAQ:ZCMD (10/10/2025, 9:04:20 PM)

After market: 0.73 -0.02 (-2.28%)

0.747

-0.07 (-8.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)09-29 2025-09-29
Earnings (Next)N/A N/A
Inst Owners0.31%
Inst Owner Change0%
Ins Owners2.4%
Ins Owner ChangeN/A
Market Cap18.97M
Analysts0
Price TargetN/A
Short Float %0.89%
Short Ratio9.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.52
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.46%
ROE -8.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.49%
FCFM N/A
ROA(3y)-18.84%
ROA(5y)-8.61%
ROE(3y)-25.29%
ROE(5y)-12.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y-3.95%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.15
Quick Ratio 8.15
Altman-Z 2.79
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)431.45%
Cap/Depr(5y)380.13%
Cap/Sales(3y)11.64%
Cap/Sales(5y)9.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.64%
Revenue growth 3Y-0.89%
Revenue growth 5Y1.29%
Sales Q2Q%-32.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.12%
OCF growth 3YN/A
OCF growth 5YN/A